fbpx

QQQ
-0.26
373.24
-0.07%
BTC/USD
-1139.55
42449.98
-2.61%
DIA
+ 0.28
347.28
+ 0.08%
SPY
+ 0.54
442.64
+ 0.12%
TLT
-1.47
149.83
-0.99%
GLD
-0.17
163.68
-0.11%

Benzinga's Top Upgrades, Downgrades For July 9, 2019

July 9, 2019 9:02 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Top Upgrades

  • Analysts at Raymond James upgraded Square Inc (NYSE:SQ) from Underperform to Market Perform. Square rose 1% to $74.15 in pre-market trading.
  • Wells Fargo upgraded Six Flags Entertainment Corp (NYSE:SIX) from Market Perform to Outperform. Six Flags rose 0.7% to $52.65 in pre-market trading.
  • Stephens & Co. upgraded FB Financial Corp (NYSE:FBK) from Equal-Weight to Overweight. FB Financial fell 1% to close at $36.54 on Monday.
  • Bank of America upgraded VEON Ltd (NASDAQ:VEON) from Neutral to Buy. VEON shares rose 1.9% to $3.17 in pre-market trading.
  • Stephens & Co. upgraded First Merchants Corporation (NASDAQ:FRME) from Equal-Weight to Overweight. First Merchants shares fell 1.7% to close at $37.57 on Monday.
  • Analysts at National Securities upgraded Sonim Technologies Inc (NASDAQ:SONM) from Neutral to Buy. Sonim Technologies shares fell 1.6% to close at $11.38 on Monday.

 

Top Downgrades

  • RBC Capital downgraded 3M Co (NYSE:MMM) from Outperform to Sector Perform. 3M fell 1.3% to $166.99 in pre-market trading.
  • JP Morgan downgraded Marriott International Inc (NASDAQ:MAR) from Overweight to Neutral. Marriott shares fell 0.5% to close at $141.30 on Monday.
  • Stephens & Co. downgraded Triumph Bancorp Inc (NASDAQ:TBK) from Overweight to Equal-Weight. Triumph Bancorp shares fell 0.9% to close at $28.84 on Monday.
  • Macquarie downgraded Alcoa Corp (NYSE:AA) from Outperform to Neutral. Alcoa shares fell 1.5% to $21.97 in pre-market trading.
  • Oppenheimer downgraded QEP Resources Inc (NYSE:QEP) from Outperform to Perform. QEP Resources shares fell 0.6% to close at $7.25 on Monday.
  • Cowen & Co. downgraded Myriad Genetics, Inc. (NASDAQ:MYGN) from Outperform to Market Perform. Myriad Genetics shares fell 2.1% to $26.64 in pre-market trading.
  • JP Morgan downgraded Hilton Hotels Corporation (NYSE:HLT) from Overweight to Neutral. Hilton Worldwide shares fell 0.4% to close at $100.19 on Monday.
  • Stephens & Co. downgraded Pinnacle Financial Partners (NASDAQ:PNFP) from Overweight to Equal-Weight. Pinnacle Financial shares rose 0.3% to $56.77 in pre-market trading.
  • Citi downgraded Leidos Holdings Inc (NYSE:LDOS) from Buy to Neutral. Leidos shares fell 0.5% to $81.00 in pre-market trading.

 

Top Initiations

  • Wells Fargo initiated coverage on Chewy Inc (NYSE:CHWY) with an Outperform rating. The price target for Chewy is set to $40. Chewy shares closed at $34.40 on Monday.
  • Stephens & Co. initiated coverage on ESCO Technologies Inc. (NYSE:ESE) with an Equal-Weight rating. The price target for ESCO Technologies is set to $87. ESCO Technologies shares closed at $81.86 on Monday.
  • Analysts at Stifel initiated coverage on AAR Corp. (NYSE:AIR) with a Buy rating. The price target for AAR is set to $50. AAR shares closed at $37.66 on Monday.
  • Analysts at Oppenheimer initiated coverage on Slack Technologies Inc (NYSE:WORK) with a Perform rating. Slack shares closed at $35.00 on Monday.
  • Bank of America initiated coverage on NextCure Inc (NASDAQ:NXTC) with a Buy rating. NextCure shares closed at $15.73 on Monday.
  • Analysts at Baird initiated coverage on Intellia Therapeutics Inc (NASDAQ:NTLA) with an Outperform rating. The price target for Intellia Therapeutics is set to $23. Intellia Therapeutics shares closed at $15.68 on Monday.
  • Analysts at Longbow Research initiated coverage on Microchip Technology Inc. (NASDAQ:MCHP) with a Neutral rating. Microchip shares closed at $87.93 on Monday.
  • Stephens & Co. initiated coverage on Hubbell Incorporated (NYSE:HUBB) with an Overweight rating. The price target for Hubbell is set to $140. Hubbell shares closed at $128.86 on Monday.
  • Oppenheimer initiated coverage on Apellis Pharmaceuticals Inc (NASDAQ:APLS) with an Outperform rating. The price target for Apellis Pharmaceuticals is set to $52. Apellis Pharmaceuticals closed at $25.92 on Monday.
  • Morgan Stanley initiated coverage on Chewy Inc (NYSE:CHWY) with an Equal-Weight rating. The price target for Chewy is set to $33. Chewy shares closed at $34.40 on Monday.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to Benzinga Podcasts and our YouTube channel.


Related Articles

Benzinga's Top Upgrades, Downgrades For June 16, 2020

Upgrades read more

Benzinga's Top Upgrades, Downgrades For March 24, 2020

Benzinga's Top Upgrades, Downgrades For January 21, 2020

Benzinga's Top Upgrades, Downgrades For January 17, 2020